http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1634085-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efd09c296645384c4e1c770411f7aa01
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-64
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
filingDate 2004-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_565f5745f09eac70ae10ac3aef92198e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7dfbed3470f0ddd20995d32f9d110a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2c165e157017fb7935f94b0b97579cd
publicationDate 2009-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1634085-B1
titleOfInvention Relaxin as an independent risk factor predicting mortality
abstract Disclosed are methods of characterising life expectancy of human individuals on the basis of measured relaxin levels. In one aspect of the invention the human individuals are end-stage-kidney-disease patients.
priorityDate 2003-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129627858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016

Total number of triples: 22.